Navigation Links
Smoking ban dramatically reduces air pollution in Irish pubs

A national workplace ban on smoking in Ireland resulted in an 83 percent reduction in air pollution in pubs, an 80 percent decrease in airborne carcinogens for patrons and staff, and an improvement in the respiratory health of bar workers, according to a one-year follow-up study.

The research appears in the second issue for April 2007 of the American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society.

Luke Clancy, M.D., B.Sc., Director of the Research Institute for a Tobacco Free Society in Dublin, and four associates examined the effect of the world's first national smoking ban on environmental tobacco smoke exposure in 42 Dublin pubs and among 73 male bar staff members who received pre- and post-ban lung function tests. Participants were tested prior to the March 29, 2004 national smoking ban, and again one-year later.

Among the barworkers, the self-reported workplace exposure to environmental tobacco smoke was over 40 hours per week pre-ban, but dropped to about 25 minutes post-ban, showing a 99 percent decrease in exposure.

Post-ban tests also demonstrated an 83 percent reduction in tiny particulate matter in bar air.

"These results confirm that the approach of a total ban on smoking in the workplace is successful in reducing the exposure of workers to particles," said Dr. Clancy. "We have previously shown that a reduction of particle levels in ambient air resulted in marked health benefits in terms of respiratory and cardiovascular mortality."

According to the investigators, the volatile hydrocarbon benzene was used as a marker for carcinogenic substances because cigarette smoke is a well-known source. They noted that there was an 80.2 percent reduction in benzene concentrations in pubs after the ban, having already established the ambient outdoor levels for benzene in Dublin.

Among the bar staff, pulmonary function tests improved dramatically in non-sm oking barmen post-ban; the workers also showed reductions in self-reported health symptoms. In addition, the non-smoking employees demonstrated significant improvements in cough and phlegm production. Moreover, sensory irritant symptoms improved in all subgroups after the ban, although the smoking workers benefited less.

In an editorial on the research in the same issue of the journal, Fiona Godfrey, B.A., L.L.M. (Master of Laws), European Union Policy Advisor at the European Respiratory Society in Brussels, wrote:

"The article by Drs. Clancy and colleagues adds to the evidence from other studies that what smoke-free advocates have said all along is true: Comprehensive smoking bans in bars dramatically reduce the levels of fine-particulate matter, chemicals and gases in the air and improve bar workers' health."

If all European countries were to adopt a similar policy, she estimates that between 5 to 10 million premature deaths from smoking could be prevented over the next generation.

Although Dr. Godfrey admits that the impact of the Irish ban has been "enormous," she also highlights several "important caveat[s]" to the study's findings.

While the health of ex- and non-smoking barmen improved significantly, the respiratory health of smokers continued to decline, with the exception of irritant sensitivity.

"Given the known health effects of secondhand smoke exposure and the reported reduction in mean exposure from 40.5 hours pre-ban to 0.42 hours post-ban, this is a disappointing finding, especially since the reported exposure outside the workplace also decreased by 42 percent," she said.

She also noted that because the study relied on volunteers, it only involved men. Given the lack of sex-specific studies on women and occupational disease and evidence that secondhand smoke exposure levels are often underestimated in non-smoking women, she calls the absence of female subjects "unfortunate, alt hough unavoidable."

"The significant improvement in the health of the nonsmoking bar workers is very welcome, but the findings of the study underline we still need to do much more to help smokers quit and enable them to share the benefits of smoke-free policies," Dr. Godfrey continued.


'"/>

Source:American Thoracic Society


Related biology news :

1. Smoking damages key regulatory enzyme in the lung
2. Smoking changes brain chemistry
3. New miniaturised chip dramatically reduces time taken for DNA analysis
4. Caloric restriction wont dramatically extend life span in humans: UCLA research
5. Hospitalizations because of chicken pox down dramatically since implementation of vaccine
6. Simple idea to dramatically improve dengue vaccinations
7. Lack of a key enzyme dramatically increases resistance to sepsis
8. Growing nerve cells in 3-D dramatically affects gene expression
9. Male circumcision reduces risk of HIV transmission from women to men
10. Deficiency of growth hormone and IGF-1 reduces cancer and kidney disease, but creates other problems
11. New processing method reduces peanut allergenicity
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/20/2017)... , March 20, 2017 At this year,s ... -based biometrics manufacturer DERMALOG. The Chancellor came to the DERMALOG stand ... is this year,s CeBIT partner country. At the largest German biometrics ... in use: fingerprint, face and iris recognition as well as DERMALOGĀ“s multi-biometrics ... ...
(Date:3/9/2017)... FRANCISCO and MOUNTAIN VIEW, Calif. ... , "Eating Well Made Simple," and 23andMe , ... help guide better food choices.  Zipongo can now provide ... their food preferences, health goals and biometrics, but also ... certain food choices. Zipongo,s personalized food decision ...
(Date:3/2/2017)... , March 2, 2017 Summary ... better understand Merck KGaA and its partnering interests and ... https://www.reportbuyer.com/product/3605601/ Description The Partnering Deals and Alliance ... partnering activity of one of the world,s leading life ... prepared upon purchase to ensure inclusion of the most ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... 2017  BioPharmX Corporation (NYSE MKT: BPMX), a ... market, today reported financial results for the quarter ... provide an update on the company,s clinical development ... "We are pleased to report that last year ... President Anja Krammer. "We achieved key clinical milestones ...
(Date:3/23/2017)... 2017 According to a report by Transparency ... fragmented due to the presence of a large pool of participants; ... Fisher , and Sigma-Aldrich, compete with each other in this market. ... more than 76% of this market in 2016.  ... As of now, a large number ...
(Date:3/22/2017)... , March 22, 2017 Regeneron Pharmaceuticals, Inc. ... Regeneron Genetics Center (RGC), U.K. Biobank and GSK to generate ... U.K. Biobank resource. The initiative will enable researchers to gain ... medicines for a wide range of serious and life threatening ... ...
(Date:3/22/2017)... CAMBRIDGE, Mass. , March 22, 2017 ... announced that it has eclipsed the 130 million covered ... Cross Blue Shield of Texas . ... stages, the Company continues to enjoy strong payor acceptance ... of its clinical programs and genetic counseling, its industry-leading ...
Breaking Biology Technology: